Beyond Celiac Calls for Heightened Focus on Driving Research for Treatment and a Cure for Celiac Disease by 2030 After Phase 3 Drug Trial Is Halted

/PRNewswire/ -- Despite yesterday's announcement by 9 Meters Biopharma that larazotide acetate drug trials had been discontinued, Beyond Celiac remains...

Related Keywords

United States ,Philadelphia ,Pennsylvania ,Angela Miller ,Claire Baker ,Patrick Griffin ,Research News ,Beyond Celiac ,Alice Bast ,Chief Medical Officer ,